Schedule 13G ownership disclosure
KERYX BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 492515101
Event date: 2015-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-16-002643
- Form type
- SC 13G
- Filer
- ABRAMS CAPITAL MANAGEMENT, L.P.
- CIK
- CIK 1358706
- Filed
- Feb 12, 2016
- Reporting period
- Dec 31, 2015
- Description
- Schedule 13G beneficial ownership